euromicron AG
11.09.2017 - Equity Research Report (english) // buy
Research study (update) – euromicron AG - english
| For the original study, please click here |
ISIN: DE000A1K0300
Branche: Biotechnologie-Pharma
Rating: buy
Kurs bei Erstellung in €: 8,42
Kursziel in €: 10,50
Mögl. Interessenskonflikt gem. §34b Abs.1 WpHG und FinAnv: 5a;5b;7;11
The euromicron Group unites medium-sized high-tech companies from the “Digital Buildings”, “Industry 4.0” and “Critical Infrastructures” sectors. As a German specialist for digitised infrastructures, euromicron enables its customers to network business and production processes and successfully move to a digital future. From design and implementation, operation, right up to intelligent services, the companies in the euromicron Group provide their customers with tailored solutions for technologies, system integration and smart services and create the IT, network and security infrastructures required for them. euromicron also assists its customers in migrating existing infrastructures gradually to the digital age. The euromicron Group’s expertise helps the company’s customers increase their own flexibility and efficiency, as well as develop new business models that lay the foundation for commercial success in the future.
Wichtiger Hinweis:
Bitte beachten Sie den Disclaimer/Risikohinweis sowie die Offenlegung möglicher Interessenskonflikte nach §34b WpHG /FinAnV auf unserer Webseite.
Artikel drucken